Samsung Biologics reports over 26% increase in Q1 net income on strong sales
Samsung Biologics, the biotech arm of Korea's Samsung Group, said Wednesday its net profit jumped 26.5 percent on-year in the first quarter thanks to strong sales.
Stay updated with breaking news from Songdo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Samsung Biologics, the biotech arm of Korea's Samsung Group, said Wednesday its net profit jumped 26.5 percent on-year in the first quarter thanks to strong sales.
(Page 1) Wood plc (Aberdeen, U.K.) has been selected by leading biopharmaceutical firm, Celltrion, to expand its Songdo biopharma manufacturing hub in Incheon,
LONDON – 4 April 2024 – Wood, a global leader in consulting and engineering, has been selected by leading biopharmaceutical firm, Celltrion, to expand its Songdo biopharma manufacturing hub in Incheon, South Korea.Under this contract, Wood will provide detailed engineering design for a new facility that...
South Korea’s growing biopharmaceutical production capacity is increasingly making the country an attractive investment destination for global life science companies, industry sources said Thursday. Since 2016, global pharmaceutical and biotech firms started building their research and development centers and production facilities in Korea, especially within the Songdo Bio Cluster in Incheon, where the biopharm...
The Incheon Bridge in South Korea is one of the longest bridges in the world.